the Safety and Efficacy of Meplazumab in Patients With COVID-19
Clinical trial NCT05113784 · COMPLETED
Trial details
- NCT number
- NCT05113784
- Sponsor
- Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-21
- Primary completion
- 2022-09-20
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.